NCT01027988

Brief Summary

Earlier studies have found that retinal photography could be very useful for evaluating the condition of microcirculation and the risk of cardiovascular diseases in patients. The architectural changes in retinal vascularisation strongly correlates with macrovascular remodeling. Also, recent founding suggests a possible close anatomical parallel between both the macrovascular and the microvascular blood. Our objectives are to assess (1) in which age and sex subgroups, if any, retinal vascular alteration in arterioles and venules can be predictive for cardiovascular morbidity and mortality; and (2) whether variations in arteriolar or venular caliber will predict better cardiovascular pathogenesis in normal and patient population. If the association between the diameter of the retinal vessels and the risks of cardiovascular disease is verified during this study, the impact on prevention would be enormous. The retinal microvascular change could become a powerful biomarker in the early detection of the cardiovascular pathogenesis and death risk

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2009

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2009

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

December 7, 2009

Completed
2 days until next milestone

First Posted

Study publicly available on registry

December 9, 2009

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2011

Completed
2.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2013

Completed
Last Updated

October 30, 2013

Status Verified

October 1, 2013

Enrollment Period

2 years

First QC Date

December 7, 2009

Last Update Submit

October 29, 2013

Conditions

Keywords

Retinal MicrovascularisationFundusmfERGsCHFCardiovascular DiseaseCoronarographyMacrovascularisationThe objectives are to assess if if any retinal vascular disorder in arterioles and venules can be predictive for cardiovascular morbidity and mortality

Outcome Measures

Primary Outcomes (1)

  • Occurrence of a major cardiovascular event or complication, defined as hospitalization, death from coronary heart disease, hypertension, arteriosclerosis, nonfatal non-procedure-related myocardial infarction, or fatal or nonfatal stroke

    2 years

Secondary Outcomes (2)

  • Characterization of any retinal vascular disorders occurring at any time during the study: i. Confirmed by an ophthalmologist examination and either an fundus camera or an mfERGs examination ii. Occurrence of serious ophthalmic event

    2 years

  • Correlation with possible cardiovascular event

    2 years

Eligibility Criteria

Age50 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

(50 to 70 years old) with history of coronary heart disease (CHD) or one or more risk factors.

You may qualify if:

  • Age between 50 to 70 years old (male/female)
  • indication of coronarography within the last 3 month preceding the enrollment
  • Patients with history of stroke, heart failure or arteriosclerosis.
  • At least one of the following risk factors for cardiovascular complication:
  • Hypertension
  • Coronary heart disease (CHD)
  • Diabetes
  • Structural heart disease
  • Dyslipidemia
  • Obesity

You may not qualify if:

  • Patients with a permanent pacemaker or ICD
  • Nephrosis or chronic renal failure
  • The study interferes with therapeutic or diagnostic procedures
  • Patients with inability to consent or comply with follow up requirements
  • Patients with glaucoma
  • Patients with any retina degeneration disease vascular age-related macular degeneration or any -retina degeneration disease
  • Patients who are pregnant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Montreal Heart Institute, 5000 Belanger Street

Montreal, Quebec, HIT IC8, Canada

Location

MeSH Terms

Conditions

Cardiovascular Diseases

Study Officials

  • Bernard Thibault, MD

    Montreal Heart Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Cardiologist - Electrophysiologist

Study Record Dates

First Submitted

December 7, 2009

First Posted

December 9, 2009

Study Start

September 1, 2009

Primary Completion

September 1, 2011

Study Completion

October 1, 2013

Last Updated

October 30, 2013

Record last verified: 2013-10

Locations